Year-end Sale % OFF 
Abstract
The incidence of solid tumor malignancy in adults following solid organ transplantation is higher than the population (6 fold increased risk) with non-melanoma skin cancers (NMSC's) being the most common. While a high incidence of post-transplant lymphoproliferative disorders (PTLD) is widely recognized in pediatric transplant recipients, the incidence of solid tumors following pediatric heart transplantation has not previously been reported. We sought to analyze the occurrence of non-PTLD malignancies in pediatric heart transplant (htx) recipients and determine the impact of such malignancies on outcome.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
